CME Group CME Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | 64.9%+0.7pp | 64.1%+2.6pp | 61.6%+1.5pp | 60.1%+3.7pp | |
| Net margin | 62.5%+4.9pp | 57.5%-0.3pp | 57.8%+4.2pp | 53.6%-2.6pp | |
| Returns | |||||
| Return on equity | 14.8%+1.5pp | 13.2%+1.2pp | 12%+2.1pp | 9.9%+0.1pp | |
| Return on invested capital | 15.2%+1.0pp | 14.3%+2.0pp | 12.3%+1.7pp | 10.6%+1.4pp | |
| Efficiency | |||||
| Asset turnover | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Liquidity | |||||
| Current ratio | 1×0.0× | 1×0.0× | 1×0.0× | 1×0.0× | |
| Leverage | |||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | 0.1×0.0× | |
| Net debt / EBITDA | -0.2×-0.4× | 0.2×0.0× | 0.3×-0.1× | 0.4×0.0× | |
| Per Share | |||||
| Book value per share | $79.73+8.4% | $73.59-1.1% | $74.38-0.6% | $74.83-2.0% | |
| Valuation | |||||
| Market capitalization | $86.61B-14.9% | $83.69B+10.4% | $75.81B+25.3% | $60.49B-26.3% | |
| Price / earnings | 20.2×-6.9× | 23.7×+0.2× | 23.5×+1.0× | 22.5×-8.7× | |
| Price / sales | 12.8×-3.0× | 13.7×+0.1× | 13.6×+1.5× | 12.1×-5.5× | |
| Price / book | 3.3×-0.4× | 3.2×+0.3× | 2.8×+0.6× | 2.3×-0.7× | |
| EV / EBITDA | 19.1×-4.8× | 20.9×-0.6× | 21.6×+2.0× | 19.6×-10.2× | |
| Dividend yield | 4.7%+0.9pp | 4.3%0.0pp | 4.3%-0.1pp | 4.4%+1.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do CME Group's ratios come from?
- Every ratio is computed from CME Group's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
